Latest Operational Efficiency News

FINEOS Corporation Holdings PLC reported a seasonal decline in cash balance and customer receipts in Q4 2024, while successfully onboarding new clients and maintaining a robust North American pipeline.

Nuchev Limited has reported its first positive operating cashflow quarter alongside a 65% increase in revenue for the first half of FY25, driven by strong sales growth and the bWellness acquisition.

Grange Resources delivered a robust December quarter with increased pellet and concentrate output, a stronger cash position, and key advancements in its North Pit Underground Project.

NeuRizer Ltd has resolved key regulatory delays for its NeuRizer Urea Project, significantly cut operating costs, and is forging international partnerships to expand its In Situ Gasification technology.

NoviqTech has entered a strategic partnership with Evercity to integrate their platforms and expand blockchain-enabled carbon market solutions, targeting emerging markets like East Africa.

Boss Energy has declared commercial production effective January 1, 2025, reporting strong quarterly uranium output growth and a robust financial position. The company remains on track to deliver 850,000 pounds of U3O8 in FY2025 amid ongoing ramp-up and expansion initiatives.

Renascor Resources has marked significant progress in its Purified Spherical Graphite (PSG) demonstration plant development, securing a site and completing initial production runs ahead of commissioning in late 2025.

Strata Minerals Ltd is set to commence its inaugural drilling program at the Penny South Gold Project in Western Australia, targeting extensions of world-class high-grade gold deposits. Concurrently, exploration activities are gearing up at the Biranup Gold Project, promising a busy year ahead for the ASX-listed explorer.

AVADA Group Limited reports a positive cash flow for Q4 2024, supported by increased collections and operational consolidation, even as government funding shifts delay project starts.

Holista Colltech Limited reports a notable financial recovery in 4QFY24, underpinned by strong cash inflows and a rebound in its Food Ingredients division, alongside a leadership change aimed at steering future growth.

Algorae Pharmaceuticals reports robust progress in its drug development pipeline, highlighted by promising preclinical results for cardiovascular and dementia candidates and significant AI platform enhancements.

CurveBeam AI has reported a record quarter for HiRise™ device purchase orders, driven by a strategic expansion with Stryker in Australia and New Zealand. The company also advanced its FDA regulatory pathway for its BMD module, setting sights on mid-2025 submission.